# Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)

> **NCT00387972** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **GlaxoSmithKline**

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** denagliptin (GW823093)

## Key facts

- **NCT ID:** NCT00387972
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-05
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study cancelled before enrollment
- **Last updated:** 2015-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00387972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00387972, "Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00387972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*